A landmark 68-week randomized controlled trial found that once-weekly semaglutide combined with lifestyle intervention produced a mean body weight reduction of approximately 14.9% compared to approximately 2.4% with placebo
Unlike traditional medications such as disulfiram, naltrexone, and buprenorphine, which primarily target neurotransmitter pathways directly associated with addiction, GLP-1RAs modulate reward mechanisms indirectly through metabolic and neuroendocrine pathways
A BMI of 27 or higher if you have a related health condition, such as type 2 diabetes, obstructive sleep apnea, high cholesterol, or hypertension
Replacing refined grains with whole grains is a simple change that supports GLP-1s effects and helps with better food choices throughout the day
The tablet is placed on the tongue and dissolves within 30 to 60 seconds